SFM
DARE icon

Sphera Funds Management’s Dare Bioscience DARE Stock Holding History

Sphera Funds Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,750
Closed -$954K – 114
2016
Q2 		$954K Buy
+3,750
New +$1.2M 0.25% 78

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sphera Funds Management's DARE Position: Q3 2016 in Review

Sphera Funds Management sold out of Dare Bioscience (DARE) in Q3 2016, closing a stake of 3,750 shares — an estimated $954K sold.

Sphera Funds Management first reported a position in DARE in Q2 2016 and held it in 1 quarter. The position peaked at $954K in Q2 2016. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2016.

  • Sphera Funds Management reported no remaining Dare Bioscience position as of Q3 2016 after selling out during the quarter.
  • Sphera Funds Management sold 3,750 Dare Bioscience shares in Q3 2016, an estimated $954K.
  • Sphera Funds Management first reported a position in Dare Bioscience in Q2 2016 and held it in 1 quarter.
  • Sphera Funds Management's Dare Bioscience position peaked at $954K in Q2 2016.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2016.

Based on Sphera Funds Management's 13F filing for Q3 2016, filed 14 Nov 2016.